Evidence recommends the non-invasive vagus nerve stimulation as a promising therapeutic alternative for cluster headache (CH) management.
With a considerable reduction in the duration, severity and attack frequency of cluster headache, non-invasive vagus nerve stimulation (nVNS) provides exalted outcomes in the context of headache management.
Evidence recommends the non-invasive vagus nerve stimulation as a promising therapeutic alternative for cluster headache (CH) management. This investigation focused on treatment-refractory CH patients to investigate early UK clinical experience with nVNS applied acutely, preventively, or both.
Total of 30 participants was selected. All participants had acted to adjunctive nVNS therapy
during an assessment period. Information obtained from treatment diaries,
physician notes and patient interviews were compiled with descriptive
statistics. Student’s two tailed paired T-test was used for statistical
significance.
The mean (SD) CH attack frequency, attack duration and severity reduced to 9.5 attacks/wk., 29.4 minutes, and 6.0 from 26.6 attacks/wk., 51.9 minutes and 7.8, respectively. Application of abortive therapies was also decreased. Beneficial changes in the employment of preventive medicine were also reported. No device-associated severe adverse events were seen.
The introduction of nVNS significantly reduces the CH
severity, duration and attack frequency.
The Journal of Headache and Pain
Non-invasive vagus nerve stimulation for treatment of cluster headache: early UK clinical experience.
Juana Marin et al.
Comments (0)